Skip to content

Farmadec

Active Private limited companyfounded 2008active for 18 yearsLouwijn 33, 1730 AsseKBO/BCE: BE 0896.835.274 subsidiary of

Lifetime

18 annual accounts with figures on one time axis
peak of €189,298 in 2011
€45,948▼ 64.6%
lowest -€32,030 in 2025
-€32,030▼ €68,015
peak of €195,583 in 2024
€163,553▼ 16.4%
€391,178▼ 20.2%
Board2 names since 2022
2 directors and 1 other
Owners
100%
Documentsfilings and deeds
14-07-202617 days before the deadline
2025abbreviated format
Gross margin from €129,724 to €45,948Loss of €32,030Equity from €195,583 to €163,553Debts from €490,335 to €391,178Cash from €46,033 to €31,727

Key points

from the 2025 annual accounts

Result

-€32,030 -€32,030
€36,0002024-€32,0002025

From profit to loss in 2025, after a profit of €35,985 in 2024.

Debts

€391,178 71% of the balance sheet
Financial debts 54%Suppliers 10%Other 35%

Of this, €177,228 falls due within a year.

Filings

17 annual accounts 18 filings since 2009
AprilJune31 JulyOctober2010201520202025

The 2016 accounts came 31 days late. The other nine of the last ten were filed on time.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 1,425 companies had the same profile as Farmadec has now. Each dot stands for 4 companies, two years later.

96.5%
were still trading
2.2%
stopped another way
1.0%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 10 to 30%
  • a small loss

Another 0.4% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 1,425 companies, not a prediction for Farmadec. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
  • 100%score equity €1.5m (2025) · annual accounts 2025 of
Board & ownership

Recent changes

Registered office moved to Asse The registered office moved to Louwijn 33, 1730 Asse · General meeting of 23-09-2026 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0896835274
Amendment of the articles · Legal-form change General meeting of 21-06-2024 · Gazette deed
New establishment in Lennik De Maeyer Lennik, Ninoofsesteenweg 74
All 30 events

Comparable companies

same main activity, similar in size and age
Company
Farmadec Asse €554,731 €45,948 29.5% -
APOTHEEK BROEKAERT Ghent €544,288 €47,761 76.6% -
HERMELIZE Dilbeek €473,074 €45,028 -14.7% -
PHARMACIE SAINTE-ANNE Dinant €597,945 €47,593 41.7% -
PHARMACIE B.ROLAND Yvoir €653,942 €49,987 91.3% -
Apotheek Schockaert M. Dendermonde €473,175 €47,103 25.4% -
VRB FARMA Mechelen €551,620 €46,476 63.4% -

These companies have the same main activity as Farmadec: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €473,000 and €654,000, founded between 2005 and 2011.

Official details

Source: KBO
Status
Active since 31-03-2008Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment units
2.326.894.0021700 Dilbeek, since 31-03-2008
2.326.894.3961750 Lennik, since 01-01-2022
Financial year end
31 December
Peppol
Reachable since 24-11-2023
Company details

Annual accounts 2025

≈ €210,000estimated
€554,731▼ 19.1%
Filing
Filed on 14-07-2026, 17 days before the end of the filing period
Financials

Insights on Farmadec

Farmadec files the abbreviated format. That format states no turnover. The gross margin rose from €34,530 in 2009 to €45,948 in 2025.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Farmadec

What is the company number of Farmadec?
The company number of Farmadec is 0896.835.274. The VAT number is the same number with BE in front: BE 0896.835.274.
Where is Farmadec based?
The registered office is at Louwijn 33, 1730 Asse.Company details
What does Farmadec do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Farmadec?
Farmadec is a private limited company (BV).
When was Farmadec founded?
Farmadec was founded on 31-03-2008.
Is Farmadec still active?
Yes, Farmadec is an active enterprise in the KBO register.
What is the turnover of Farmadec?
The turnover in financial year 2025 is ≈ €210,000. This figure is estimated from the gross margin of €45,948 and 71 comparable companies (NACE 477). It probably lies between €120,000 and €390,000.Financials
Is Farmadec profitable?
In financial year 2025, Farmadec made a loss of €32,030.
Where can I find the annual accounts of Farmadec?
Farmadec filed 18 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Farmadec due?
Farmadec must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.